Completed PHASE1 INTERVENTIONAL 2-arm NCT02399982

Smartphone Technology and CBT-GSH in Binge Eaters

Innovative Use of the Noom Monitor Mobile Application for CBT-GSH in Binge Eaters

Sponsor: Icahn School of Medicine at Mount Sinai

Conditions Binge Eating Disorder Bulimia Nervosa

Updated 5 times since 2017 Last updated: May 2, 2016 Started: Feb 28, 2013 Primary completion: Mar 31, 2016 Completion: Mar 31, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE1 trial investigates Binge Eating Disorder and Bulimia Nervosa and is currently completed. Icahn School of Medicine at Mount Sinai leads this study, which shows 5 recorded versions since 2013 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1
Jun 2018 — Jan 2021 [monthly]

Completed PHASE1
Jan 2017 — Jun 2018 [monthly]

Completed PHASE1

First recorded

Feb 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Icahn School of Medicine at Mount Sinai
Kaiser Foundation Hospitals, Center for Health Research
National Institute of Mental Health (NIMH)
Noom Inc.

Data source: Icahn School of Medicine at Mount Sinai

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• New York, United States